TOPICS

Category: Current Issue

Consecutive Cases of Pyoderma Gangrenosum Following Dermatologic Surgery

J Clin Aesthet Dermatol. 2020;13(8):49–50 by Brian Wanner, DO; Stephanie Saridakis, DO; and Dawn Sammons, DO Dr. Wanner is a dermatology resident, PGY-3, at OhioHealth Riverside Methodist Hospital in Columbus, Ohio. Dr. Saridakis is an intern, PGY-1, at OhioHealth Riverside Methodist Hospital in Columbus, Ohio. Dr. Sammons is Dermatology Residency Program Director at OhioHealth Riverside

CONTINUE READING »

Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up

J Clin Aesthet Dermatol. 2020;13(8):36–39 by Suparuj Lueangarun, MD, MSc; Punyaphat Sirithanabadeekul, MD; Prapalpitch Wongwicharn, MD; Chutimon Namboonlue, MD; Sarun Pacharapakornpong, MD; Premjit Juntongjin, MD; and Therdpong Tempark, MD Drs. Lueangarun, Sirithanabadeekul, Wongwicharn, Namboonlue, Pacharapakornpong, and Juntongjin are with the Division of Dermatology at the Chulabhorn International College of Medicine of Thammasat University in Pathumthani,

CONTINUE READING »

Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study

by Shilpi Sharma, MD, and Saurabh Agarwal, MD Dr. Sharma is Assistant Professor in the Department of Dermatology, Venereology, and Leprology at the Government Medical College Haldwani in Uttarakhand, India. Dr. Agarwal is Professor and Unit Head of the Department of Dermatology, Venereology, and Leprology at the Government Medical College Haldwani in Uttarakhand, India. J

CONTINUE READING »

A 14-day Controlled Study Assessing Qualitative Improvement with 15% Lactic Acid and Ceramides in Skin Moisturization and Desquamation

by Zoe Diana Draelos, MD; Steven Hall, PharmD; and Carey Munsick, MS Dr. Draelos is with Dermatology Consulting Services, PLLC, in High Point, North Carolina. Dr. Hall and Ms. Munsick are with Sandoz Inc., in Princeton, New Jersey. J Clin Aesthet Dermatol. 2020;13(8):E54–E58 FUNDING: This study was funded by PharmaDerm, a division of Fougera Pharmaceuticals.

CONTINUE READING »